1
3
(
t, 1H, J = 9.5 Hz, H-4), 5.33 (t, 1H, J = 9.0 Hz, H-3), 5.78 (d, 1H, J = 7.7 Hz, H-1); C NMR (100
MHz, CDCl ) δ 21.8 (triple intensity), 22.0, 54.8, 69.9, 71.2, 72.8, 73.8, 77.2, 77.5, 92.3, 166.7, 169.7,
70.1, 170.4, 170.8; HRMS calcd for C17 11 (+Na): 423.0903, found 423.0907. Triazole (7) was
prepared by heating azide (3) (746 mg, 2.0 mmol) and alkyne (6) (800 mg, 2.0 mmol) with CuSO
3
1
20
H O
4
(
(
0.025 mL of a 1M aqueous solution) and ascorbic acid (0.25 mL of a 1M aqueous solution) in water
o
15 mL) at 70 C for 12 h. After cooling to rt the precipitate was collected on a glass frit and washed
o
o
D
with cold methanol. Triazole (7) (1.2 g, 76%) was isolated as a tan solid: mp 204-208 C; [α] -5.8 (c
1
1
1
1
5
.2, CH
2
Cl
2
); H NMR (400 MHz, CDCl
3
, glu = glucopyranose ring, gluA = glucuronic acid ring) δ
), 3.99 (m, 1H, H-5glu), 4.14 (dd,
H, J = 2.2, 12.9 Hz, H-6glu), 4.20 (d, 1H, J = 9.7 Hz, H-5gluA), 4.29 (dd, 1H, J = 4.9, 12.6 Hz, H-6’glu),
.11-5.48 (m, 8H, H-2glu, H-2gluA, H-3glu, H-3gluA, H-4glu, H-4gluA, -OCH -triazole), 5.76 (d, 1H, J = 7.7
.89, 1.99, 2.01, 2.04, 2.08, 2.10, 2.12 (7 x s, total 24 H, 8 x COCH
3
2
1
3
Hz, H-1gluA), 5.88 (d, 1H, J = 9.0 Hz, H-1glu), 7.89 (s, 1H, triazole-H); C NMR (100 MHz, CDCl
3
) δ
1.4, 21.7, 21.8 (quadruple intensity), 21.9, 22.0, 59.9, 62.6, 68.7, 69.8, 71.2, 71.3, 72.9, 73.7, 73.8,
6.2, 86.8, 92.3, 124.0, 143.0, 167.2, 169.7, 169.8, 170.1, 170.2, 170.5, 170.7, 170.8, 171.4; HRMS
20 (+Na): 796.2025, found 796.2031.
7. Alkyne (8) was prepared in 80% yield by treating 1,2:3,4-di-O-isopropylidene-D-galactopyranose
2
7
39 3
calcd for C31H N O
1
o
o
1
with propargyl bromide and KOH in MeCN: mp 50-54 C; [α]
D
-3.2 (c 1.0, CH
), 2.44 (t, 1H, J = 2.0 Hz,
alkyne-H), 3.67 (dd, 1H, J = 7.1, 10.1 Hz, H-6), 3.78 (dd, 1H, J = 5.2, 10.2 Hz, H-6’), 4.00 (m, 1H,
H-5), 4.17-4.33 (m, 4H, H-2, H-4, propargyl CH ), 4.61 (dd, 1H, J = 2.3, 8.0 Hz, H-3), 5.55 (d, 1H, J
) δ 25.7, 26.1, 27.2, 27.3, 59.6, 67.8, 69.8, 71.5, 71.7,
2.2, 75.8, 80.7, 97.4, 109.6, 110.3; HRMS calcd for C H O (+Na): 321.1314, found 321.1297.
2 2
Cl ); H NMR
(400 MHz, CDCl
3
) δ 1.33, 1.35, 1.46, 1.55 (4 x s, 3H each, 4 x CH
3
2
1
3
=
5.1 Hz, H-1); C NMR (100 MHz, CDCl
3
7
1
5
22
6
Triazole (9) was formed in a similar fashion to compound (7) with the addition of t-BuOH as a
co-solvent. Thus, azide (3) (2.61 g, 7.0 mmol), alkyne (8) (2.09 g, 7.0 mmol), CuSO (0.05 mL of a
M aqueous solution) and ascorbic acid (0.5 mL of a 1M aqueous solution) in water were heated in a
4
1
o
mixture of water (10 mL) and t-BuOH (10 mL) at 70 C for 90 min. After evaporating the t-BuOH the
precipitate was filtered and washed with cold water to give triazole (9) (3.97 g, 84%) as a colorless
o
o
1
powder: mp 160-163 C; [α]
D
-44.3 (c 1.1, CHCl
3
); H NMR (400 MHz, CDCl
3
, glu = glucopyranose
), 1.88, 2.04, 2.08,
), 3.68 (dd, 1H, J = 7.0, 10.1 Hz, H-6gal), 3.74 (dd, 1H, J = 5.6, 10.2
Hz, H-6’gal), 4.00 (m, 2H, H-5glu, H-5gal), 4.12 (dd, 1H, J = 1.5, 12.5, H-6glu), 4.25-4.33 (m, 3H,
H-6’glu, H-2gal, H-3gal), 4.61 (dd, 1H, J = 2.2, 7.9 Hz, H-4gal), 4.68 (m, 2H, -OCH -triazole), 5.24 (t,
H, J = 9.4 Hz, H-4glu), 5.40 (m, 2H, H-2glu, H-3glu), 5.56 (d, 1H, J = 4.9 Hz, H-1gal), 5.89 (d, 1H, J =
ring, gal = galactopyranose ring) δ 1.34, 1.35, 1.45, 1.54 (4 x s, 3H each, 4 x CH
.09 (4 x s, 3H each, 4 x COCH
3
2
3
2
1
8
1
3
.8 Hz, H-1glu), 7.84 (s, 1H, triazole-H); C NMR (100 MHz, CDCl ) δ 21.4, 21.7, 21.8, 21.9, 25.7,
3